I too think HEPI has $1+ potential. Market cap less than $40 million. Inflammation has untold applications. Autoimmune also has significant application potential. A new discovery in this arena is worth far more than $40 million. Add cholesterol and a potential acquisition .... And there is a good risk reward profile.
Separation of the strains within the biomass should yield much better chance to ID the bioactives as well and make not only the algae but the bioactives scalable in a predictable controlled process by a qualified manufacturer.